Heartflow Inc
HTFL27.740USD
+1.750+6.73%
Handelsschluss 02/06, 16:00（ET）Kurse um 15 Minuten verzögert
2.32BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Heartflow Inc Unternehmen
HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.
Heartflow Inc Informationen
BörsenkürzelHTFL
Name des UnternehmensHeartflow Inc
IPO-datumAug 08, 2025
CEOFarquhar (John C. M)
Anzahl der mitarbeiter699
WertpapierartOrdinary Share
GeschäftsjahresendeAug 08
Addresse331 E Evelyn Avenue
StadtMOUNTAIN VIEW
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl94041
Telefon16502411221
Websitehttps://www.heartflow.com/
BörsenkürzelHTFL
IPO-datumAug 08, 2025
CEOFarquhar (John C. M)
Führungskräfte von Heartflow Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Vikram Verghese
Mr. Vikram Verghese
Chief Financial Officer
Chief Financial Officer
123.86K
-471.00%
Mr. Jeffrey C. Lightcap
Mr. Jeffrey C. Lightcap
Independent Director
Independent Director
40.00K
+40000.00%
Mr. Lonnie M. Smith
Mr. Lonnie M. Smith
Independent Director
Independent Director
34.25K
+34246.00%
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
16.45K
+16447.00%
Dr. Charles A. Taylor, Ph.D.
Dr. Charles A. Taylor, Ph.D.
Director
Director
--
--
Dr. Campbell D. Rogers, M.D.
Dr. Campbell D. Rogers, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. John C. M. Farquhar
Mr. John C. M. Farquhar
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Julie Cullivan
Ms. Julie Cullivan
Independent Director
Independent Director
--
--
Mr. Tim Barabe
Mr. Tim Barabe
Independent Director
Independent Director
--
--
Dr. Wayne Riley, M.D.
Dr. Wayne Riley, M.D.
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Vikram Verghese
Mr. Vikram Verghese
Chief Financial Officer
Chief Financial Officer
123.86K
-471.00%
Mr. Jeffrey C. Lightcap
Mr. Jeffrey C. Lightcap
Independent Director
Independent Director
40.00K
+40000.00%
Mr. Lonnie M. Smith
Mr. Lonnie M. Smith
Independent Director
Independent Director
34.25K
+34246.00%
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
16.45K
+16447.00%
Dr. Charles A. Taylor, Ph.D.
Dr. Charles A. Taylor, Ph.D.
Director
Director
--
--
Dr. Campbell D. Rogers, M.D.
Dr. Campbell D. Rogers, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
United states
42.95M
92.80%
United kingdom
1.52M
3.28%
Japan
1.46M
3.16%
Rest of europe
349.00K
0.75%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Aktionärsstatistik
Aktualisiert: Sun, Feb 8
Aktualisiert: Sun, Feb 8
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Bain Capital Life Sciences Investors, LLC
12.27%
HealthCor Partners Management LP
7.86%
Wellington Management Company, LLP
5.73%
Fidelity Management & Research Company LLC
5.42%
Capricorn Investment Group LLC
4.61%
Andere
64.11%
Aktionäre
Aktionäre
Anteil
Bain Capital Life Sciences Investors, LLC
12.27%
HealthCor Partners Management LP
7.86%
Wellington Management Company, LLP
5.73%
Fidelity Management & Research Company LLC
5.42%
Capricorn Investment Group LLC
4.61%
Andere
64.11%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
51.66%
Investment Advisor/Hedge Fund
12.52%
Hedge Fund
3.17%
Individual Investor
2.46%
Endowment Fund
0.37%
Bank and Trust
0.32%
Private Equity
0.18%
Sovereign Wealth Fund
0.15%
Pension Fund
0.14%
Andere
29.04%
Institutionelle Beteiligung
Aktualisiert: Wed, Jan 21
Aktualisiert: Wed, Jan 21
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q4
129
59.51M
43.48%
--
2025Q4
149
60.27M
70.78%
+21.99M
2025Q3
46
45.42M
54.46%
+42.91M
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Bain Capital Life Sciences Investors, LLC
12.45M
14.62%
--
--
Sep 30, 2025
HealthCor Partners Management LP
6.70M
7.86%
--
--
Sep 30, 2025
Wellington Management Company, LLP
4.88M
5.73%
+465.57K
+10.55%
Sep 30, 2025
Fidelity Management & Research Company LLC
4.62M
5.42%
+1.33M
+40.42%
Sep 30, 2025
Capricorn Investment Group LLC
3.92M
4.61%
+3.92M
--
Aug 08, 2025
Hayfin Capital Management LLP
3.64M
4.27%
-1.00
-0.00%
Sep 30, 2025
Baillie Gifford & Co.
3.01M
3.53%
+415.89K
+16.06%
Sep 30, 2025
Schusterman Interests LLC
1.94M
2.28%
+1.94M
--
Sep 30, 2025
The Vanguard Group, Inc.
1.45M
1.7%
+285.27K
+24.45%
Sep 30, 2025
Capital International Investors
1.30M
1.52%
+1.30M
--
Sep 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
TrueShares Technology, AI & Deep Learning ETF
3.13%
Global X HealthTech ETF
1.75%
Fidelity Blue Chip Growth ETF
0.07%
T Rowe Price Small-Mid Cap ETF
0.06%
iShares Health Innovation Active ETF
0.02%
Schwab U.S. Small-Cap ETF
0.02%
Fidelity Nasdaq Composite Index ETF
0.01%
Schwab U.S. Broad Market ETF
0%
TrueShares Technology, AI & Deep Learning ETF
Anteil3.13%
Global X HealthTech ETF
Anteil1.75%
Fidelity Blue Chip Growth ETF
Anteil0.07%
T Rowe Price Small-Mid Cap ETF
Anteil0.06%
iShares Health Innovation Active ETF
Anteil0.02%
Schwab U.S. Small-Cap ETF
Anteil0.02%
Fidelity Nasdaq Composite Index ETF
Anteil0.01%
Schwab U.S. Broad Market ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
